Giulia Trucco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giulia Trucco has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Raggi
Neurology, Public Health and Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
1 shared publication - Alessia Marcassoli
Neurology, Public Health and Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
1 shared publication - Alice Colombo
Neurology, Public Health and Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
1 shared publication - Angelica Mazzilli
Neurology, Public Health and Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy
1 shared publication - Barbara Corso
Neuroscience Institute, National Research Council, Padova, Italy
1 shared publication - Carlo Antozzi
Immunotherapy and Apheresis Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
1 shared publication
Latest Publications
- 6 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (1) , 111
Does myasthenia gravis impact cognitive functioning? A systematic review and meta-analysis
Background Myasthenia Gravis, traditionally known as a purely motor disease, has been recently associated also with non-motor symptoms, including psychological and cognitive symptoms. However, the presence of cognitive impairment in Myasthenia Gravis remains unclear due to limited and heterogeneous findings. This systematic review and meta-analysis aims to clarify the relationship between Myasthenia Gravis and cognitive performances. Methods Following PRISMA guidelines, we systematically searched PubMed, Web of Science, and SCOPUS for original researches published between January 2000 and December 2024 assessing cognitive functioning in people with MG compared to healthy controls. Pooled standardized mean differences and 95% confidence intervals were calculated for each cognitive domain using random-effects meta-analysis. Results Six studies comprising 242 Myasthenia Gravis patients and 166 healthy controls met inclusion criteria. Compared to healthy controls, people with Myasthenia Gravis showed significantly lower performance in processing speed (Symbol Digit Modalities Test), phonemic and animal verbal fluency, visuo-spatial memory (visual reproduction), and verbal learning (California Verbal Learning Test). Heterogeneity was low to moderate across most outcomes. Conclusions This meta-analysis supports the presence of selective cognitive impairments in individuals with Myasthenia Gravis. These findings underscore the need for a multidimensional approach to care in Myasthenia Gravis, that includes cognitive and psychological health.
- 6 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (1) , 111
Does myasthenia gravis impact cognitive functioning? A systematic review and meta-analysis
Background Myasthenia Gravis, traditionally known as a purely motor disease, has been recently associated also with non-motor symptoms, including psychological and cognitive symptoms. However, the presence of cognitive impairment in Myasthenia Gravis remains unclear due to limited and heterogeneous findings. This systematic review and meta-analysis aims to clarify the relationship between Myasthenia Gravis and cognitive performances. Methods Following PRISMA guidelines, we systematically searched PubMed, Web of Science, and SCOPUS for original researches published between January 2000 and December 2024 assessing cognitive functioning in people with MG compared to healthy controls. Pooled standardized mean differences and 95% confidence intervals were calculated for each cognitive domain using random-effects meta-analysis. Results Six studies comprising 242 Myasthenia Gravis patients and 166 healthy controls met inclusion criteria. Compared to healthy controls, people with Myasthenia Gravis showed significantly lower performance in processing speed (Symbol Digit Modalities Test), phonemic and animal verbal fluency, visuo-spatial memory (visual reproduction), and verbal learning (California Verbal Learning Test). Heterogeneity was low to moderate across most outcomes. Conclusions This meta-analysis supports the presence of selective cognitive impairments in individuals with Myasthenia Gravis. These findings underscore the need for a multidimensional approach to care in Myasthenia Gravis, that includes cognitive and psychological health.